Hyperthermic intraperitoneal chemotherapy in the treatment of recurrent ovarian cancer: When, and for whom?
Ali AyhanHüseyin AkıllıMehmet Ali AbasiyanikCagatay TaskıranPublished in: Journal of surgical oncology (2022)
HIPEC at the time of first platinum-sensitive relapse may lead to favorable PFS in the treatment ROC. However, HIPEC as salvage treatment even with R0 cytoreductive surgery does not seem effective.